Scienture Holdings, Inc.
SCNX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001382574
No open-market purchases or sales by Scienture Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $709.1K in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Scienture Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 11 | 15 | +4 |
| Shares | 527.3K | 643.8K | +116.4K (+22.1%) |
| Value | $2.60M | $1.52M | −$1.08M (−41.6%) |
New holders (6)
Institutions that held Scienture Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ridgewood Investments LLC | 94,900 | $224.0K | 0.14% |
| Citadel Advisors LLC | 25,756 | $60.0K | 0.00% |
| Renaissance Technologies LLC | 21,600 | $51.0K | 0.00% |
| Susquehanna International Group, LLP | 21,335 | $50.0K | 0.00% |
| Virtu Financial LLC | 17,447 | $41.0K | 0.00% |
| Morgan Stanley | 5,248 | $12.0K | 0.00% |
Sold out (2)
Institutions that held Scienture Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| International Assets Investment Management, LLC | 14,500 | $71.0K |
| UBS Group AG | 5,425 | $27.0K |